191 related articles for article (PubMed ID: 35868215)
1. CCR1 antagonist J-113863 corrects the imbalance of pro- and anti-inflammatory cytokines in a SJL/J mouse model of relapsing-remitting multiple sclerosis.
Ansari MA; Nadeem A; Attia SM; Bakheet SA; Shahid M; Rehman MU; Alanazi MM; Alhamed AS; Ibrahim KE; Albekairi NA; Ahmad SF
Immunobiology; 2022 Sep; 227(5):152245. PubMed ID: 35868215
[TBL] [Abstract][Full Text] [Related]
2. CCR1 antagonist ameliorates experimental autoimmune encephalomyelitis by inhibition of Th9/Th22-related markers in the brain and periphery.
Al-Mazroua HA; Nadeem A; Ansari MA; Attia SM; Bakheet SA; Albekairi TH; Ali N; Alasmari F; Algahtani M; Alsaad AMS; Ahmad SF
Mol Immunol; 2022 Apr; 144():127-137. PubMed ID: 35219910
[TBL] [Abstract][Full Text] [Related]
3. Mitogen-activated protein kinase inhibitor PD98059 improves neuroimmune dysfunction in experimental autoimmune encephalomyelitis in SJL/J mice through the inhibition of nuclear factor-kappa B signaling in B cells.
Alomar HA; Nadeem A; Ansari MA; Attia SM; Bakheet SA; Al-Mazroua HA; Alhazzani K; Assiri MA; Alqinyah M; Almudimeegh S; Ahmad SF
Brain Res Bull; 2023 Mar; 194():45-53. PubMed ID: 36646144
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic treatment against GM-CSF, but not IL-17, abolishes relapses in a chronic murine model of multiple sclerosis.
Uyttenhove C; Gaignage M; Donckers D; Nasr Z; Cheou P; van Snick J; D'Auria L; van Pesch V
Eur J Immunol; 2018 Nov; 48(11):1883-1891. PubMed ID: 30216414
[TBL] [Abstract][Full Text] [Related]
5. Opioid growth factor and low-dose naltrexone impair central nervous system infiltration by CD4 + T lymphocytes in established experimental autoimmune encephalomyelitis, a model of multiple sclerosis.
Hammer LA; Waldner H; Zagon IS; McLaughlin PJ
Exp Biol Med (Maywood); 2016 Jan; 241(1):71-8. PubMed ID: 26202376
[TBL] [Abstract][Full Text] [Related]
6. CC chemokine receptor 5 antagonist alleviates inflammation by regulating IFN-γ/IL-10 and STAT4/Smad3 signaling in a mouse model of autoimmune encephalomyelitis.
Ahmad SF; Nadeem A; Ansari MA; Bakheet SA; Shahid M; Al-Mazroua HA; As Sobeai HM; Alasmari AF; Alanazi MM; Alhamed AS; Aldossari AA; Attia SM
Cell Immunol; 2022 Sep; 379():104580. PubMed ID: 35872534
[TBL] [Abstract][Full Text] [Related]
7. The translocator protein ligand XBD173 improves clinical symptoms and neuropathological markers in the SJL/J mouse model of multiple sclerosis.
Leva G; Klein C; Benyounes J; Hallé F; Bihel F; Collongues N; De Seze J; Mensah-Nyagan AG; Patte-Mensah C
Biochim Biophys Acta Mol Basis Dis; 2017 Dec; 1863(12):3016-3027. PubMed ID: 28899788
[TBL] [Abstract][Full Text] [Related]
8. MAP kinase inhibitor PD98059 regulates Th1, Th9, Th17, and natural T regulatory cells in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis.
Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Alasmari AF; Shahid M; Al-Mazroua HA; Alomar HA; AsSobeai HM; Alshamrani AA; Attia SM
Eur J Pharmacol; 2023 Nov; 959():176086. PubMed ID: 37832863
[TBL] [Abstract][Full Text] [Related]
9. Histamine H4 Receptor Antagonist Ameliorates the Progression of Experimental Autoimmune Encephalomyelitis via Regulation of T-Cell Imbalance.
Aldossari AA; Assiri MA; Ansari MA; Nadeem A; Attia SM; Bakheet SA; Albekairi TH; Alomar HA; Al-Mazroua HA; Almanaa TN; Al-Hamamah MA; Alwetaid MY; Ahmad SF
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894952
[TBL] [Abstract][Full Text] [Related]
10. Cathepsin B inhibitor alleviates Th1, Th17, and Th22 transcription factor signaling dysregulation in experimental autoimmune encephalomyelitis.
Ansari MA; Nadeem A; Alshammari MA; Attia SM; Bakheet SA; Khan MR; Albekairi TH; Alasmari AF; Alhosaini K; Alqahtani F; Al-Mazroua HA; Ahmad SF
Exp Neurol; 2022 May; 351():113997. PubMed ID: 35122866
[TBL] [Abstract][Full Text] [Related]
11. Decreased severity of experimental autoimmune encephalomyelitis during resveratrol administration is associated with increased IL-17+IL-10+ T cells, CD4(-) IFN-gamma+ cells, and decreased macrophage IL-6 expression.
Imler TJ; Petro TM
Int Immunopharmacol; 2009 Jan; 9(1):134-43. PubMed ID: 19022403
[TBL] [Abstract][Full Text] [Related]
12. Histamine H4 Receptor Agonist, 4-Methylhistamine, Aggravates Disease Progression and Promotes Pro-Inflammatory Signaling in B Cells in an Experimental Autoimmune Encephalomyelitis Mouse Model.
Alsaad AMS; Ansari MA; Nadeem A; Attia SM; Bakheet SA; Alomar HA; Ahmad SF
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629172
[TBL] [Abstract][Full Text] [Related]
13. Protective Effects on Central Nervous System by Acidic Polysaccharide of Panax ginseng in Relapse-Remitting Experimental Autoimmune Encephalomyelitis-Induced SJL/J Mice.
Bing SJ; Ha D; Hwang I; Park E; Ahn G; Song JY; Jee Y
Am J Chin Med; 2016; 44(6):1099-1110. PubMed ID: 27627913
[TBL] [Abstract][Full Text] [Related]
14. Lymph node-derived donor encephalitogenic CD4+ T cells in C57BL/6 mice adoptive transfer experimental autoimmune encephalomyelitis highly express GM-CSF and T-bet.
Cravens PD; Hussain RZ; Zacharias TE; Ben LH; Herndon E; Vinnakota R; Lambracht-Washington D; Nessler S; Zamvil SS; Eagar TN; Stüve O
J Neuroinflammation; 2011 Jun; 8():73. PubMed ID: 21702922
[TBL] [Abstract][Full Text] [Related]
15. Central nervous system gene therapy with interleukin-4 inhibits progression of ongoing relapsing-remitting autoimmune encephalomyelitis in Biozzi AB/H mice.
Furlan R; Poliani PL; Marconi PC; Bergami A; Ruffini F; Adorini L; Glorioso JC; Comi G; Martino G
Gene Ther; 2001 Jan; 8(1):13-9. PubMed ID: 11402297
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of inflammatory cytokines parallels progression of central nervous system pathology in two clinically distinct models of multiple sclerosis.
Begolka WS; Vanderlugt CL; Rahbe SM; Miller SD
J Immunol; 1998 Oct; 161(8):4437-46. PubMed ID: 9780223
[TBL] [Abstract][Full Text] [Related]
17. Carvacrol ameliorates experimental autoimmune encephalomyelitis through modulating pro- and anti-inflammatory cytokines.
Mahmoodi M; Amiri H; Ayoobi F; Rahmani M; Taghipour Z; Ghavamabadi RT; Jafarzadeh A; Sankian M
Life Sci; 2019 Feb; 219():257-263. PubMed ID: 30472298
[TBL] [Abstract][Full Text] [Related]
18. Bifidobacterium animalis in combination with human origin of Lactobacillus plantarum ameliorate neuroinflammation in experimental model of multiple sclerosis by altering CD4+ T cell subset balance.
Salehipour Z; Haghmorad D; Sankian M; Rastin M; Nosratabadi R; Soltan Dallal MM; Tabasi N; Khazaee M; Nasiraii LR; Mahmoudi M
Biomed Pharmacother; 2017 Nov; 95():1535-1548. PubMed ID: 28946394
[TBL] [Abstract][Full Text] [Related]
19. Neutralization of Interleukin-9 Decreasing Mast Cells Infiltration in Experimental Autoimmune Encephalomyelitis.
Yin JJ; Hu XQ; Mao ZF; Bao J; Qiu W; Lu ZQ; Wu HT; Zhong XN
Chin Med J (Engl); 2017 Apr; 130(8):964-971. PubMed ID: 28397727
[TBL] [Abstract][Full Text] [Related]
20. A potent and selective CXCR2 antagonist improves neuroimmune dysregulation through the inhibition of NF-κB and notch inflammatory signaling in the BTBR mouse model of autism.
Alomar HA; Ansari MA; Nadeem A; Attia SM; Bakheet SA; Al-Mazroua HA; Hussein MH; Alqarni SA; Ahmad SF
J Neuroimmunol; 2023 Apr; 377():578069. PubMed ID: 36931207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
